amifampridine has been researched along with Carcinoma, Small Cell Lung in 3 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, SJ | 1 |
| Gill, AJ | 1 |
| Gandhy, S | 1 |
| Lancaster, E | 1 |
| Uekita, K | 1 |
| Ishida, T | 1 |
| Sekine, S | 1 |
| Ishii, T | 1 |
| Sato, S | 1 |
| Sugawara, A | 1 |
| Tachihara, M | 1 |
| Watanabe, K | 1 |
| Kanazawa, K | 1 |
| Saito, J | 1 |
| Tanino, Y | 1 |
| Munakata, M | 1 |
1 trial available for amifampridine and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Amifampridine to treat Lambert-Eaton myasthenic syndrome.
Topics: Adult; Amifampridine; Child; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Small Cell L | 2020 |
2 other studies available for amifampridine and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Nivolumab-associated Lambert-Eaton myasthenic syndrome and cerebellar dysfunction in a patient with a neuroendocrine tumor.
Topics: Amifampridine; Antineoplastic Combined Chemotherapy Protocols; Calcium Channels, P-Type; Calcium Cha | 2021 |
[A case of Lambert-Eaton myasthenic syndrome with small cell lung cancer, treated with 3,4-diaminopyridine].
Topics: 4-Aminopyridine; Aged; Amifampridine; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Mal | 2009 |